EUVIMEDEUVIMED entdecken
Crossref

Thermosensitive multivesicular liposomal hydrogel: a potential platform for loco-regional drug delivery in the treatment of osteomyelitis caused by antibiotic-resistant biofilm-forming bacteria

Melody Vatankhah, Arash Mahboubi, Reyhaneh Varshochian, Azadeh Haeri, Hamidreza Houri, Zahra Abbasian, Simin Dadashzadeh iD

Letters in Applied Microbiology · 01.10.2024 · 77 (10)

DOI: 10.1093/lambio/ovae092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Applied Microbiology, online erschienen am 03.10.2024. Verfasst von Melody Vatankhah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran. Hauptthemen laut MEDLINE: Biofilms, Osteomyelitis, Liposomes, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilm-mediated osteomyelitis presents significant therapeutic challenges. Given the limitations of existing osteomyelitis treatment approaches, there is a distinct need to develop a localized drug delivery system that is biocompatible, biodegradable, and capable of controlled antibiotic release. Multivesicular liposomes (MVLs), characterized by their non-concentric vesicular structure, distinct composition, and enhanced stability, serve as the system for a robust sustained-release drug delivery platform. In this study, various hydrogel formulations composed of poloxamer 407 and other hydrogels, incorporating vancomycin hydrochloride (VAN HL)-loaded MVLs (VAN HL-MVLs), were prepared and evaluated. The optimized VAN HL-MVL sol-gel system, consisting of poloxamer 407 and hyaluronic acid, successfully maintained drug release for up to 3 weeks and exhibited shear-thinning behavior at 37°C. While complete drug release from MVLs alone took place in 312 h, the hydrogel formulation extended this release to 504 h. The released drug effectively inhibited the Staphylococcus aureus biofilms growth within 24 h and methicillin-resistant S. aureus biofilms within 72 h. It also eradicated preformed biofilms of S. aureus and methicillin-resistant S. aureus in 96 and 120 h, respectively. This injectable in situ gel system incorporating VAN HL-MVLs holds potential as an alternative to undergoing multiple surgeries for osteomyelitis treatment and warrants further studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsOsteomyelitisLiposomesAnti-Bacterial AgentsHydrogelsVancomycinDrug Delivery SystemsStaphylococcus aureusMethicillin-Resistant Staphylococcus aureusHumansDrug LiberationPoloxamerStaphylococcal InfectionsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

biofilmmultivesicular liposomesosteomyelitissustained-releasethermosensitive hydrogelvancomycin hydrochloride

Substanzen

LiposomesAnti-Bacterial AgentsHydrogelsVancomycinPoloxamer

Autor:innen und Institutionen

  • Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran.
  • Department of Pharmaceutics and Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran.
  • Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran.
  • Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran.
  • Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran.

ORCID-Profile: Simin Dadashzadeh

Förderung

  • Shahid Beheshti University of Medical Sciences

Zitieren

APA

Vatankhah, M., Mahboubi, A., Varshochian, R., Haeri, A., Houri, H., Abbasian, Z., & Dadashzadeh, S. (2024). Thermosensitive multivesicular liposomal hydrogel: a potential platform for loco-regional drug delivery in the treatment of osteomyelitis caused by antibiotic-resistant biofilm-forming bacteria. Letters in Applied Microbiology, 77(10). https://doi.org/10.1093/lambio/ovae092

Vancouver

Vatankhah M, Mahboubi A, Varshochian R, Haeri A, Houri H, Abbasian Z, et al. Thermosensitive multivesicular liposomal hydrogel: a potential platform for loco-regional drug delivery in the treatment of osteomyelitis caused by antibiotic-resistant biofilm-forming bacteria. Letters in Applied Microbiology. 2024;77(10). doi:10.1093/lambio/ovae092

BibTeX
@article{Vatankhah2024,
  author = {Vatankhah, Melody and Mahboubi, Arash and Varshochian, Reyhaneh and Haeri, Azadeh and Houri, Hamidreza and Abbasian, Zahra and Dadashzadeh, Simin},
  title = {Thermosensitive multivesicular liposomal hydrogel: a potential platform for loco-regional drug delivery in the treatment of osteomyelitis caused by antibiotic-resistant biofilm-forming bacteria},
  journal = {Letters in Applied Microbiology},
  year = {2024},
  volume = {77},
  number = {10},
  doi = {10.1093/lambio/ovae092}
}
Kostenlos starten →